{"id":239770,"date":"2026-09-10T10:26:58","date_gmt":"2026-09-10T04:56:58","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=239770"},"modified":"2026-11-16T11:44:03","modified_gmt":"2026-11-16T06:14:03","slug":"why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026\/","title":{"rendered":"Symbiotec Pharmalab (SYMBIOTEC) Share Price Hits Fresh 52-Week High of Rs 1,649.00"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/symbiotec\/symbiotec-pharmalab-ltd-share-price-today\">SYMBIOTEC PHARMALAB LTD (SYMBIOTEC)<\/a> share price reached a fresh 52-week high of Rs 1,649 today and later stood at Rs 1,604.5, down 0.59% from the previous close. Market cap was Rs 10,371.26 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\">The Symbiotec Pharmalab share price is Rs 1,604.50 as of 16 November 2026 at 11:37 AM IST, down 0.59% from the previous close of Rs 1,614.05. The stock touched a fresh 52-week high of Rs 1,649.00 earlier today, and Symbiotec Pharmalab now carries a market capitalisation of Rs 10,371.26 crore.<\/p>\n<p style=\"margin-top:0!important;\">This Symbiotec Pharmalab share price update rests on the fresh 52-week high event confirmed by the Univest 52-week-high screener, and the stock now appears on the 52 Week High Stocks list. The price move is confirmed in Univest data; a company-specific reason has not been established.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026\/#Symbiotec_Pharmalab_Share_Price_Today_Price_Action_Analysis\" title=\"Symbiotec Pharmalab Share Price Today: Price Action Analysis\">Symbiotec Pharmalab Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026\/#SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC_Fundamental_Analysis\" title=\"SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Fundamental Analysis\">SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026\/#Why_Investors_Are_Watching_Symbiotec_Pharmalab\" title=\"Why Investors Are Watching Symbiotec Pharmalab\">Why Investors Are Watching Symbiotec Pharmalab<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026\/#About_Symbiotec_Pharmalab\" title=\"About Symbiotec Pharmalab\">About Symbiotec Pharmalab<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026\/#What_is_the_Symbiotec_Pharmalab_share_price_today\" title=\"What is the Symbiotec Pharmalab share price today?\">What is the Symbiotec Pharmalab share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026\/#What_is_the_Symbiotec_Pharmalab_52-week_high\" title=\"What is the Symbiotec Pharmalab 52-week high?\">What is the Symbiotec Pharmalab 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026\/#Why_is_the_Symbiotec_Pharmalab_share_price_in_focus_today\" title=\"Why is the Symbiotec Pharmalab share price in focus today?\">Why is the Symbiotec Pharmalab share price in focus today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026\/#What_is_the_market_cap_of_Symbiotec_Pharmalab\" title=\"What is the market cap of Symbiotec Pharmalab?\">What is the market cap of Symbiotec Pharmalab?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026\/#What_is_the_Symbiotec_Pharmalab_PE_ratio_compared_with_its_industry\" title=\"What is the Symbiotec Pharmalab P\/E ratio compared with its industry?\">What is the Symbiotec Pharmalab P\/E ratio compared with its industry?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026\/#What_are_the_ROE_and_ROCE_of_Symbiotec_Pharmalab\" title=\"What are the ROE and ROCE of Symbiotec Pharmalab?\">What are the ROE and ROCE of Symbiotec Pharmalab?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026\/#What_are_the_EPS_book_value_and_dividend_yield_of_Symbiotec_Pharmalab\" title=\"What are the EPS, book value and dividend yield of Symbiotec Pharmalab?\">What are the EPS, book value and dividend yield of Symbiotec Pharmalab?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026\/#How_does_Symbiotec_Pharmalab_compare_with_its_peers\" title=\"How does Symbiotec Pharmalab compare with its peers?\">How does Symbiotec Pharmalab compare with its peers?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-52-week-high-today-2026\/#Track_Symbiotec_Pharmalab_Share_Price_on_Univest\" title=\"Track Symbiotec Pharmalab Share Price on Univest\">Track Symbiotec Pharmalab Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Symbiotec_Pharmalab_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Symbiotec Pharmalab Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,604.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,614.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -9.55 (-0.59%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,608.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,649<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,596<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 10,371.26 crore<\/td>\n<\/tr>\n<\/table>\n<p>Readers following Symbiotec Pharmalab stock news can watch the day range of Rs 1,596.00 to Rs 1,649.00, the valuation against pharma industry peers, and the Sep 2026 quarter revenue of Rs 279.93 crore, all covered below.<\/p>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) traded at Rs 1,604.5 versus the previous close of Rs 1,614.05, a fall of 0.59%. The stock opened at Rs 1,608.05, reached a high of Rs 1,649 and touched a low of Rs 1,596.<\/p>\n<p>What happened to the Symbiotec Pharmalab share price today? The stock opened at Rs 1,608.05, touched a low of Rs 1,596.00 and a fresh 52-week high of Rs 1,649.00, and last traded at Rs 1,604.50, a fall of Rs 9.55 or 0.59% from the previous close of Rs 1,614.05.<\/p>\n<p>The one-year high of Rs 1,649.00 is also today&#8217;s intraday high, so the Symbiotec Pharmalab 52 week high and the day high are the same level. The stock now trades Rs 44.50 below that peak, which places the latest Symbiotec Pharmalab share price in the lower part of the day&#8217;s range.<\/p>\n<p>The opening price of Rs 1,608.05 was below the previous close of Rs 1,614.05, and the day high of Rs 1,649.00 sits Rs 34.95 above the previous close. This Symbiotec Pharmalab stock performance reading is a confirmed price fact, not a forecast, and it does not point to a reason for the move.<\/p>\n<p>For readers comparing the Symbiotec Pharmalab share price with the day&#8217;s range, the latest price is Rs 8.50 above the day low of Rs 1,596.00, inside a total band of Rs 53.00 between the low and the high. That is a simple way to read where the stock sits within today&#8217;s price action.<\/p>\n<p>Univest tracks every fresh 52-week high through its screener, which is why the Symbiotec Pharmalab share price live reading today is classed as a confirmed event. The sections below turn to valuation and fundamentals to place the move in context.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC_Fundamental_Analysis\"><\/span><strong>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 10,371.26 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">94.37x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.62x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 17.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 211.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) fundamental metrics show P\/E 94.37x, P\/B 7.62x, ROE 11.22%, ROCE 12.41%. These ratios show where the company stands today and are not a call to buy or sell.<\/p>\n<p>SYMBIOTEC PHARMALAB LTD has a market capitalisation of Rs 10,371.26 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 94.37x, P\/B at 7.62x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.22% and ROCE of 12.41%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 17.1, book value per share of Rs 211.8, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 30.49x, median ROE of 10.97%, median ROCE of 12.7%. Together they describe the fundamental backdrop without implying a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">94.37x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.49x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">51.97x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.6x to 1,177x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.62x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.88x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.97%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 10,371.26 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 677.13 crore<\/td>\n<\/tr>\n<\/table>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) operates in the Healthcare sector, within the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a P\/E ratio of 94.37x, which is above the benchmark median of 30.49x, a difference of +209.51%. A P\/E difference of this kind is a reference point rather than a recommendation.<\/p>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a ROE of 11.22%, which is above the benchmark median of 10.97%, a difference of +2.28%. SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a ROCE of 12.41%, which is below the benchmark median of 12.7%, a difference of -2.28%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/bluejet\/blue-jet-healthcare-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Blue Jet Healthcare Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BLUEJET<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10,201.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">35.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">27.18<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/pghl\/procter-and-gamble-health-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Procter &amp; Gamble Health Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">PGHL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9,666.98<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">62.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.86<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/viyash\/sequent-scientific-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sequent Scientific Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">VIYASH<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11,275.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">48.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.56<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/star\/strides-pharma-science-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Strides Pharma Science Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">STAR<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9,350.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.16<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.57<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/akums\/akums-drugs-and-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Akums Drugs &amp; Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">AKUMS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11,655.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.77<\/td>\n<\/tr>\n<\/table>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a P\/E ratio of 94.37x compared with the displayed peer median of 32.04x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.22% compares with a peer median of 19.88% across the companies shown in the table. ROCE stood at 12.41% versus the displayed peer median of 18.57%, providing a capital-efficiency comparison. SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a market capitalisation of Rs 10,371.26 crore. Among the 5 peers shown, 2 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Symbiotec_Pharmalab\"><\/span><strong>Why Investors Are Watching Symbiotec Pharmalab<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The stock touched a fresh 52-week high of Rs 1,649.00 today.<\/li>\n<li>The Symbiotec Pharmalab share price is Rs 1,604.50, down 0.59% from the previous close of Rs 1,614.05.<\/li>\n<li>P\/E of 94.37 is above the industry median of 30.49 and the industry average of 51.97.<\/li>\n<li>ROE of 11.22% is above the industry median of 10.97% and the average of 4.67%.<\/li>\n<li>Market cap of Rs 10,371.26 crore is above the industry median of Rs 677.13 crore.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Symbiotec_Pharmalab\"><\/span><strong>About Symbiotec Pharmalab<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Symbiotec Pharmalab trades on the NSE under the symbol SYMBIOTEC. Univest classifies the company in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry, which is the group used for the benchmark comparisons in this article. The latest quarterly revenue is Rs 279.93 crore for the Sep 2026 quarter.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Symbiotec_Pharmalab_share_price_today\"><\/span><strong>What is the Symbiotec Pharmalab share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 16 November 2026 at 11:37 AM IST, the Symbiotec Pharmalab share price is Rs 1,604.50, down Rs 9.55 or 0.59% from the previous close of Rs 1,614.05. It trades on the NSE as SYMBIOTEC.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Symbiotec_Pharmalab_52-week_high\"><\/span><strong>What is the Symbiotec Pharmalab 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The fresh 52-week high for Symbiotec Pharmalab is Rs 1,649.00, touched today. This one-year high is also the day high, and the stock now trades Rs 44.50 below that peak at Rs 1,604.50.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_the_Symbiotec_Pharmalab_share_price_in_focus_today\"><\/span><strong>Why is the Symbiotec Pharmalab share price in focus today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The price move is confirmed in Univest data; a company-specific reason has not been established. The fresh 52-week high of Rs 1,649.00 is a verified fact, while the cause of the move is not stated.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Symbiotec_Pharmalab\"><\/span><strong>What is the market cap of Symbiotec Pharmalab?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The market capitalisation of Symbiotec Pharmalab is Rs 10,371.26 crore. In the Pharmaceuticals &amp; Drugs benchmark of 203 companies, that is above the median of Rs 677.13 crore and below the average of Rs 14,561.14 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Symbiotec_Pharmalab_PE_ratio_compared_with_its_industry\"><\/span><strong>What is the Symbiotec Pharmalab P\/E ratio compared with its industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Symbiotec Pharmalab P\/E ratio is 94.37 against an industry median of 30.49 and an average of 51.97. The P\/B ratio is 7.62 against a median of 2.88, so both multiples sit above the median.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_ROE_and_ROCE_of_Symbiotec_Pharmalab\"><\/span><strong>What are the ROE and ROCE of Symbiotec Pharmalab?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Symbiotec Pharmalab has an ROE of 11.22% and an ROCE of 12.41%. The industry medians are 10.97% for ROE and 12.70% for ROCE, so ROE sits above the median and ROCE sits slightly below it.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_EPS_book_value_and_dividend_yield_of_Symbiotec_Pharmalab\"><\/span><strong>What are the EPS, book value and dividend yield of Symbiotec Pharmalab?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> EPS is Rs 17.10, which shows earnings attributable to each share. Book value per share is Rs 211.80, and the dividend yield is 0%, a historical payout measure relative to the current price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Symbiotec_Pharmalab_compare_with_its_peers\"><\/span><strong>How does Symbiotec Pharmalab compare with its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Against five listed peers, Symbiotec Pharmalab has a P\/E of 94.37, above Sequent Scientific at 48.48 and every other peer shown. Its market cap of Rs 10,371.26 crore is larger than three of the five peers.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Symbiotec Pharmalab share price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 16 November 2026 at 11:37 AM IST, the Symbiotec Pharmalab share price is Rs 1,604.50, down Rs 9.55 or 0.59% from the previous close of Rs 1,614.05. It trades on the NSE as SYMBIOTEC.\"}},{\"@type\":\"Question\",\"name\":\"What is the Symbiotec Pharmalab 52-week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The fresh 52-week high for Symbiotec Pharmalab is Rs 1,649.00, touched today. This one-year high is also the day high, and the stock now trades Rs 44.50 below that peak at Rs 1,604.50.\"}},{\"@type\":\"Question\",\"name\":\"Why is the Symbiotec Pharmalab share price in focus today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The price move is confirmed in Univest data; a company-specific reason has not been established. The fresh 52-week high of Rs 1,649.00 is a verified fact, while the cause of the move is not stated.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Symbiotec Pharmalab?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The market capitalisation of Symbiotec Pharmalab is Rs 10,371.26 crore. In the Pharmaceuticals & Drugs benchmark of 203 companies, that is above the median of Rs 677.13 crore and below the average of Rs 14,561.14 crore.\"}},{\"@type\":\"Question\",\"name\":\"What is the Symbiotec Pharmalab P\/E ratio compared with its industry?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Symbiotec Pharmalab P\/E ratio is 94.37 against an industry median of 30.49 and an average of 51.97. The P\/B ratio is 7.62 against a median of 2.88, so both multiples sit above the median.\"}},{\"@type\":\"Question\",\"name\":\"What are the ROE and ROCE of Symbiotec Pharmalab?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Symbiotec Pharmalab has an ROE of 11.22% and an ROCE of 12.41%. The industry medians are 10.97% for ROE and 12.70% for ROCE, so ROE sits above the median and ROCE sits slightly below it.\"}},{\"@type\":\"Question\",\"name\":\"What are the EPS, book value and dividend yield of Symbiotec Pharmalab?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"EPS is Rs 17.10, which shows earnings attributable to each share. Book value per share is Rs 211.80, and the dividend yield is 0%, a historical payout measure relative to the current price.\"}},{\"@type\":\"Question\",\"name\":\"How does Symbiotec Pharmalab compare with its peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Against five listed peers, Symbiotec Pharmalab has a P\/E of 94.37, above Sequent Scientific at 48.48 and every other peer shown. Its market cap of Rs 10,371.26 crore is larger than three of the five peers.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_Symbiotec_Pharmalab_Share_Price_on_Univest\"><\/span><strong>Track Symbiotec Pharmalab Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/symbiotec\/symbiotec-pharmalab-ltd-share-price-today\">SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Users can track the live Symbiotec Pharmalab share price, fundamental ratios, 52-week levels and market insights on Univest. Univest also keeps the peer comparison and sector benchmarks together, so readers can follow the stock after this 52-week high event. This article is for information only and carries no recommendation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SYMBIOTEC PHARMALAB LTD Share Price hit a fresh 52-week high of Rs 1,649 today and is trading at Rs 1,604.50, down 0.59% on the day. Market cap stands at Rs 10,371.26 crore.<\/p>\n","protected":false},"author":35,"featured_media":348115,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-239770","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["348115"],"rank_math_title":["Symbiotec Pharmalab Share Price Hits Fresh 52-Week High"],"rank_math_description":["Symbiotec Pharmalab share price touched a fresh 52-week high of Rs 1,649.00 and trades at Rs 1,604.50. See price action, P\/E, ROE and peer analysis."],"rank_math_focus_keyword":["Symbiotec Pharmalab Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/Symbiotec_Pharmalab_SYMBIOTEC_Share_Price_Hits_Fresh_52_Week_High_of_Rs_164900_bullish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/239770","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=239770"}],"version-history":[{"count":4,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/239770\/revisions"}],"predecessor-version":[{"id":348116,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/239770\/revisions\/348116"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/348115"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=239770"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=239770"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=239770"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}